4 ms·
> “We do not have just one vaccine. We have several.” I thought their problem was they didn't have access to vaccines over in Europe, not that they had a large
by chrisseaton 6y ago
> “We do not have just one vaccine. We have several.”
I thought their problem was they didn't have access to vaccines over in Europe, not that they had a large stock to pick and choose from.
- deleted 6y ago[deleted]
- Daho0n 6y agoIn Denmark the halt of the AstraZeneca will delay vaccinations by approximately two weeks.
- chrisseaton 6y agoThat seems like a really long time to me. Did you post this comment thinking it sounds short?
- throwawayboise 6y agoWe've been dealing with the pandemic for over a year (it was originally going to be a few weeks to "flatten the curve"). What's 2 more weeks?
- chrisseaton 6y ago> What's 2 more weeks? A few thousand dead bodies at the current rate.
- alanfranz 6y agoDenmark has ~2500 deaths since the beginning of the pandemics. Your numbers are off.
- chrisseaton 6y agoContext is across the whole of Europe. Still a couple of thousand of people dying every week in Europe.
- cinntaile 6y agoYes your original reply was, but this specific childthread is talking about Denmark and how stopping the AZ vaccine pushes back their estimates by two weeks. This will likely cause preventable death in Denmark but those numbers are not in the thousands.
- morsch 6y agoAZ is not suspended in all of Europe. Most countries continue to use it, some of them -- France and Germany among then -- limiting the vaccine to people beyond a certain age (France: 55, Germany: 60), who are at a greater risk from Covid and who are also the next large group to be vaccinated.
- chrisseaton 6y ago> limiting the vaccine to people beyond a certain age (France: 55 Wait - I thought France said AztraZeneca wasn't effective for people over 65? Are they just giving it to people 55-65 therefore? And shouldn't those people have already been vaccinated by now anyway?
- morsch 6y agoPresumably you're being intentionally obtuse, but whatever. France (and Germany) initially said the recommendation for those groups was pending additional data on efficacy in those age groups, which was lacking in the phase 3 trials. This data has since been submitted and the recommendation extended to elderly people.
- chrisseaton 6y ago> initially said the recommendation for those groups was pending additional data on efficacy in those age groups Hang on that’s not not actually what the French said is it? They actually said there was data and that the data said it was ineffective.
- henrikeh 6y agoFor what it is worth, I read it as a neutral statement: it is literally just the official estimate of the impact in terms of time.
- morsch 6y agoToday? Yes. Expected vaccine deliveries for Germany (pop. 80m): Q1: Biontech 12.4m, Moderna 1.8m, AZ 5.7m Q2: Biontech 40.2m, Moderna 6.4m, AZ 12.4-15.m, JJ: 10.1m, Curevac 1.4m 2021 (total): Biontech 100.7m, Moderna 78m, AZ: 56.3m, JJ: 36.7m, Curevac: 24.5m, Sanofi: 27.5 Source: https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloads/C/Coronavirus/Impfstoff/Lieferprognosen_verschiedene_Hersteller_2021.pdf https://www.bundesgesundheitsministerium.de/fileadmin/Dateie...
- RobertoG 6y agoThat was a temporary problem, they have started to arrive in big numbers this week. Hopefully it will keep increasing.
- chrisseaton 6y ago> That was a temporary problem I guess it's a permanent problem if you're dead because of it.
- _Microft 6y agoI think in the first quarter, BioNTech/Pfizer delivered almost 2.5 to 3 times as many doses to the EU as AZ did. Temporarily not having AZ until it is clear how to proceed is bad but not a total disaster. Encountering problems with the BioNTech/Pfizer vaccine would have been much, much worse. Moderna isn’t in widespread use here yet.